These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

172 related items for PubMed ID: 7036146

  • 61. Patient characteristics rather than the type of dialyser predict the variability of endothelial derived surface molecules in chronic haemodialysis patients.
    Grooteman MP, Gritters M, Wauters IM, Schalkwijk CG, Stam F, Twisk J, Ter Wee PM, Nubé MJ.
    Nephrol Dial Transplant; 2005 Dec; 20(12):2751-8. PubMed ID: 16188898
    [Abstract] [Full Text] [Related]

  • 62. Prostacyclin in the circulation of patients with vascular disorders undergoing surgery.
    Ritter JM, Hamilton G, Barrow SE, Heavey DJ, Hickling NE, Taylor KM, Hobbs KE, Dollery CT.
    Clin Sci (Lond); 1986 Dec; 71(6):743-7. PubMed ID: 3539459
    [Abstract] [Full Text] [Related]

  • 63. Volume-induced natriuresis in healthy women: renal metabolism of prostacyclin and thromboxane, and physiological role of prostanoids.
    Agnoli GC, Borgatti R, Cacciari M, Lenzi P, Marinelli M, Stipo L.
    Prostaglandins Leukot Essent Fatty Acids; 2001 Feb; 64(2):95-103. PubMed ID: 11237476
    [Abstract] [Full Text] [Related]

  • 64. Differential effects of angiotensin converting enzyme inhibitors on the vasodepressor and prostacyclin responses to bradykinin.
    Brown NJ, Ryder D, Gainer JV, Morrow JD, Nadeau J.
    J Pharmacol Exp Ther; 1996 Nov; 279(2):703-12. PubMed ID: 8930174
    [Abstract] [Full Text] [Related]

  • 65. Nitric oxide-mediated cyclooxygenase activation. A key event in the antiplatelet effects of nitrovasodilators.
    Salvemini D, Currie MG, Mollace V.
    J Clin Invest; 1996 Jun 01; 97(11):2562-8. PubMed ID: 8647949
    [Abstract] [Full Text] [Related]

  • 66. Enhanced prostacyclin synthesis in acute human kidney transplant rejection.
    Leithner C, Sinzinger H, Silberbauer K, Wolf A, Stummvoll HK, Pinggera W.
    Proc Eur Dial Transplant Assoc; 1980 Jun 01; 17():424-8. PubMed ID: 7017684
    [Abstract] [Full Text] [Related]

  • 67. [The prostaglandin-prostacyclin system and thrombocyte functions in patients with systemic lupus erythematosus].
    Pribytkov IuN, Poltyrev AS, Shilkina NP.
    Ter Arkh; 1992 Jun 01; 64(12):44-8. PubMed ID: 1292132
    [No Abstract] [Full Text] [Related]

  • 68. Acute renal artery constriction increases renal prostaglandin I2 biosynthesis and renin release in the conscious dog.
    Jackson EK, Gerkens JF, Brash AR, Branch RA.
    J Pharmacol Exp Ther; 1982 Aug 01; 222(2):410-3. PubMed ID: 7047717
    [Abstract] [Full Text] [Related]

  • 69. Prostacyclin is not a circulating hormone.
    Christ-Hazelhof E, Nugteren DH.
    Prostaglandins; 1981 Nov 01; 22(5):739-46. PubMed ID: 7036224
    [Abstract] [Full Text] [Related]

  • 70. Platelet hyperaggregability, blood prostacyclin and dipyridamole.
    Solvay H, Kahn M, Cloarec M, Van De Merckt J, Sneppe R, Schram E, Fenollar JV.
    Angiology; 1986 Mar 01; 37(3 Pt 1):175-84. PubMed ID: 3518548
    [Abstract] [Full Text] [Related]

  • 71. Effects of iloprost on salt-sensitive Dahl rats.
    Somova L.
    Methods Find Exp Clin Pharmacol; 1995 Sep 01; 17(7):443-7. PubMed ID: 8577205
    [Abstract] [Full Text] [Related]

  • 72. [Thrombocytic hemostasis and the system of vasoactive prostanoids in IHD patients with hypoalphacholesterolemia].
    Chernyshov VA, Tseluĭko VI, Ladnyĭ AI, Ermakovich II.
    Ter Arkh; 1995 Sep 01; 67(6):64-6. PubMed ID: 7667787
    [Abstract] [Full Text] [Related]

  • 73. Thrombocytosis in diabetic and nondiabetic end-stage renal disease patients on peritoneal dialysis.
    Sokunbi D, Wadhwa NK, Solomon M, Suh H.
    Adv Perit Dial; 1993 Sep 01; 9():156-60. PubMed ID: 8105912
    [Abstract] [Full Text] [Related]

  • 74. Glucose-added dialysis fluid prevents asymptomatic hypoglycaemia in regular haemodialysis.
    Burmeister JE, Scapini A, da Rosa Miltersteiner D, da Costa MG, Campos BM.
    Nephrol Dial Transplant; 2007 Apr 01; 22(4):1184-9. PubMed ID: 17272314
    [Abstract] [Full Text] [Related]

  • 75. Soluble P-selectin during a single hemodialysis session in patients with chronic renal failure and erythropoietin treatment.
    Stasko J, Galajda P, Ivanková J, Hollý P, Rozborilová E, Kubisz P.
    Clin Appl Thromb Hemost; 2007 Oct 01; 13(4):410-5. PubMed ID: 17911193
    [Abstract] [Full Text] [Related]

  • 76. A prostacyclin-sparing effect of indobufen vs. aspirin.
    De Caterina R, Giannessi D, Bernini W, Lazzerini G, Lavezzari M, Stragliotto E, Biagi G, Coccheri S.
    Thromb Haemost; 1996 Mar 01; 75(3):510-4. PubMed ID: 8701417
    [Abstract] [Full Text] [Related]

  • 77. Stability of prostacyclin in human plasma and whole blood: studies on the protective effect of albumin.
    Orchard MA, Robinson C.
    Thromb Haemost; 1981 Oct 01; 46(3):645-7. PubMed ID: 7031983
    [Abstract] [Full Text] [Related]

  • 78. Systemic levels of 6-keto-prostaglandin F1 alpha following administration of inhaled aerosolized prostacyclin.
    van Heerden PV.
    Anaesth Intensive Care; 1997 Dec 01; 25(6):701-3. PubMed ID: 9452859
    [Abstract] [Full Text] [Related]

  • 79. Altered platelet and vascular prostaglandin-generation in patients with renal failure and prolonged bleeding times.
    Remuzzi G, Marchesi D, Livio M, Cavenaghi AE, Mecca G, Donati MB, de Gaetano G.
    Thromb Res; 1978 Dec 01; 13(6):1007-15. PubMed ID: 373157
    [No Abstract] [Full Text] [Related]

  • 80. Measurement of human venous plasma prostacyclin and metabolites by radioimmunoassay: a reappraisal.
    Forder RA, Carey F.
    Prostaglandins Leukot Med; 1983 Nov 01; 12(3):323-46. PubMed ID: 6361783
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.